AKEBIA THERAPEUTICS INC (AKBA) Top Institutional Shareholders

AKEBIA THERAPEUTICS INC (AKBA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $137.27M in AKBA holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of AKBA tracked by InsiderSet, reporting ownership valued at approximately $25.98M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $19.07M, representing an estimated loss of -26.62% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed AKBA value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., State Street Corp, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in AKEBIA THERAPEUTICS INC (AKBA).

This page ranks the largest institutional AKBA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

167

Total Reported Value

$137.27M

Largest Holder

Blackrock, Inc.

Largest Position

$25.98M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

196

Funds Exiting Positions

0

Page 1 of 4
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%18,693,296$25,983,682$19,067,162-$6,916,520-26.62%
State Street Corp0.00%11,614,006$16,143,468$11,846,286-$4,297,182-26.62%
Vanguard Capital Management Llc0.00%11,166,710$15,521,727$11,390,044-$4,131,683-26.62%
Geode Capital Management, Llc0.00%6,452,252$8,970,938$6,581,297-$2,389,641-26.64%
Goldman Sachs Group Inc0.00%3,602,827$5,007,930$3,674,884-$1,333,046-26.62%
Citigroup Inc0.00%2,854,586$3,967,875$2,911,678-$1,056,197-26.62%
Bank Of America Corp0.00%2,763,362$3,841,073$2,818,629-$1,022,444-26.62%
Qube Research & Technologies Ltd0.00%2,395,215$3,329,349$2,443,119-$886,230-26.62%
Millennium Management Llc0.00%2,384,713$3,314,751$2,432,407-$882,344-26.62%
Vanguard Portfolio Management Llc0.00%2,215,441$3,079,463$2,259,750-$819,713-26.62%
Charles Schwab Investment Management Inc0.00%2,015,577$2,801,652$2,055,889-$745,763-26.62%
Nantahala Capital Management, Llc0.17%2,000,000$2,780,000$2,040,000-$740,000-26.62%
Northern Trust Corp0.00%1,945,586$2,704,364$1,984,498-$719,866-26.62%
Renaissance Technologies LLCJim Simons0.00%1,833,128$2,548,048$1,869,791-$678,257-26.62%
Aqr Capital Management Llc0.00%1,792,620$2,491,742$1,828,472-$663,270-26.62%
Vanguard Fiduciary Trust Co0.00%1,779,301$2,473,228$1,814,887-$658,341-26.62%
Jane Street Group, Llc0.00%1,456,674$2,024,777$1,485,807-$538,970-26.62%
Citadel Advisors Llc0.00%1,390,067$1,932,194$1,417,868-$514,326-26.62%
Fmr Llc0.00%1,335,328$1,856,107$1,362,035-$494,072-26.62%
Two Sigma Investments, Lp0.00%1,297,801$1,803,943$1,323,757-$480,186-26.62%
Dimensional Fund Advisors Lp0.00%921,923$1,280,467$940,361-$340,106-26.56%
Ubs Group Ag0.00%769,471$1,069,564$784,860-$284,704-26.62%
Susquehanna International Group, Llp0.00%722,119$1,003,745$736,561-$267,184-26.62%
Invesco Ltd.0.00%720,139$1,000,993$734,542-$266,451-26.62%
Wellington Management Group Llp0.00%707,745$983,765$721,900-$261,865-26.62%
Voleon Capital Management Lp0.02%675,656$939,162$689,169-$249,993-26.62%
Bnp Paribas Financial Markets0.00%665,630$925,226$678,943-$246,283-26.62%
Bank Of New York Mellon Corp0.00%650,851$904,682$663,868-$240,814-26.62%
Hennion & Walsh Asset Management, Inc.0.03%633,253$880,222$645,918-$234,304-26.62%
Los Angeles Capital Management Llc0.00%601,308$835,818$613,334-$222,484-26.62%
Nuveen, Llc0.00%596,599$829,272$608,531-$220,741-26.62%
Morgan Stanley0.00%581,327$808,044$592,954-$215,090-26.62%
Jacobs Levy Equity Management, Inc0.00%429,669$597,240$438,262-$158,978-26.62%
Squarepoint Ops Llc0.00%422,828$587,731$431,285-$156,446-26.62%
American Century Companies Inc0.00%415,988$578,223$424,308-$153,915-26.62%
Mangrove Partners Im, Llc0.04%375,954$522,576$383,473-$139,103-26.62%
Rafferty Asset Management, Llc0.00%327,110$454,683$333,652-$121,031-26.62%
Virtus Advisers, Llc0.20%308,000$428,120$314,160-$113,960-26.62%
Rhumbline Advisers0.00%306,926$426,616$313,065-$113,551-26.62%
Canada Pension Plan Investment Board0.00%287,500$399,625$293,250-$106,375-26.62%
Alliancebernstein L.P.0.00%238,930$384,677$243,709-$140,968-36.65%
Connor, Clark & Lunn Investment Management Ltd.0.00%274,431$381,459$279,920-$101,539-26.62%
Man Group Plc0.00%257,854$358,417$263,011-$95,406-26.62%
Graham Capital Management, L.P.0.01%248,352$345,209$253,319-$91,890-26.62%
Xtx Topco Ltd0.01%244,453$339,790$249,342-$90,448-26.62%
Panagora Asset Management Inc0.00%236,111$328,194$240,833-$87,361-26.62%
Alps Advisors Inc0.00%218,070$303,117$222,431-$80,686-26.62%
Entrypoint Capital, Llc0.08%201,749$280,431$205,784-$74,647-26.62%
Sapient Capital Llc0.00%200,000$278,000$204,000-$74,000-26.62%
Russell Investments Group, Ltd.0.00%196,561$273,218$200,492-$72,726-26.62%

Frequently asked questions about AKBA

  • Who owns the most AKBA stock?

    The largest holders of AKBA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for AKEBIA THERAPEUTICS INC (AKBA).

  • Is AKBA widely held by superinvestors?

    Many widely followed stocks like AKBA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AKBA is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.